Socioeconomic Status and Long-term Outcomes in Single Ventricle Heart Disease

Emily M Bucholz1,2, Lynn A Sleeper1,2, Caren S Goldberg3

  • 1Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.

Pediatrics
|September 25, 2020
PubMed

Insights

Children with hypoplastic left heart syndrome from low socioeconomic status (SES) backgrounds experience worse long-term neurodevelopmental and functional outcomes. These disparities persist regardless of clinical factors.

Area of Science:

  • Pediatric Cardiology
  • Developmental Pediatrics
  • Health Outcomes Research

Background:

  • Low socioeconomic status (SES) is a known risk factor for short-term mortality and neurodevelopmental issues in children with hypoplastic left heart syndrome (HLHS).
  • Long-term effects of SES on HLHS outcomes remain largely uncharacterized.

Purpose of the Study:

  • To investigate the long-term impact of neighborhood socioeconomic status (SES) on mortality, neurodevelopment, quality of life, and functional status in children with HLHS.
  • To analyze the relationship between SES and outcomes 5-6 years after the Norwood procedure.

Main Methods:

  • Linked data from the Single Ventricle Reconstruction trial with US Census Bureau data.
  • Analyzed neighborhood SES tertiles in relation to mortality, transplantation, neurodevelopment, quality of life, and functional status (N=525).
  • Employed Cox proportional hazards regression and linear regression for outcome assessment.

Main Results:

  • Patients in the lowest SES tertile had higher unadjusted mortality (41% vs. 29%) and were more likely to be racial minorities.
  • Lowest SES group reported significantly lower functional status and impaired fine motor, problem-solving, adaptive behavior, and communication skills at 6 years.
  • Quality of life did not differ significantly between SES groups.

Conclusions:

  • Low SES is associated with poorer neurodevelopmental and functional status outcomes at 6 years in children with HLHS.
  • These SES-related disparities are not explained by other patient or clinical characteristics.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
208
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
176
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
506
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
234
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
369
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
147